Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Transition from fresh frozen plasma to solvent/detergent plasma in the Netherlands: comparing clinical use and transfusion reaction risks.

Saadah NH, Schipperus MR, Wiersum-Osselton JC, van Kraaij MG, Caram-Deelder C, Beckers EAM, Leyte A, Rondeel JMM, de Vooght KMK, Weerkamp F, Zwaginga JJ, van der Bom JG.

Haematologica. 2019 Jul 4. pii: haematol.2019.222083. doi: 10.3324/haematol.2019.222083. [Epub ahead of print]

2.

Updated definitions for respiratory complications of blood transfusion.

Schipperus MR, Wiersum-Osselton JC; ISBT-IHN-AABB TACO Definition Revision Group.

Transfusion. 2019 Jul;59(7):2482-2483. doi: 10.1111/trf.15389. No abstract available.

PMID:
31268594
3.

Revised international surveillance case definition of transfusion-associated circulatory overload: a classification agreement validation study.

Wiersum-Osselton JC, Whitaker B, Grey S, Land K, Perez G, Rajbhandary S, Andrzejewski C Jr, Bolton-Maggs P, Lucero H, Renaudier P, Robillard P, Santos M, Schipperus M.

Lancet Haematol. 2019 Jul;6(7):e350-e358. doi: 10.1016/S2352-3026(19)30080-8. Epub 2019 May 9.

PMID:
31080132
4.

International haemovigilance: what have we learned and what do we need to do next?

Wood EM, Ang AL, Bisht A, Bolton-Maggs PH, Bokhorst AG, Flesland O, Land K, Wiersum-Osselton JC, Schipperus MR, Tiberghien P, Whitaker BI.

Transfus Med. 2019 Aug;29(4):221-230. doi: 10.1111/tme.12582. Epub 2019 Feb 6. Review.

PMID:
30729612
5.

International validation of harmonized definitions for complications of blood donations.

Land KJ, Townsend M, Goldman M, Whitaker BI, Perez GE, Wiersum-Osselton JC.

Transfusion. 2018 Nov;58(11):2589-2595. doi: 10.1111/trf.14948. Epub 2018 Oct 8.

PMID:
30294786
6.

Transfusion reactions after transfusion of platelets stored in PAS-B, PAS-C, or plasma: a nationwide comparison.

van Hout FMA, van der Meer PF, Wiersum-Osselton JC, Middelburg RA, Schipperus MR, van der Bom JG, Kerkhoffs JL.

Transfusion. 2018 Apr;58(4):1021-1027. doi: 10.1111/trf.14509. Epub 2018 Feb 6.

PMID:
29405304
7.

Comparing transfusion reaction risks for various plasma products - an analysis of 7 years of ISTARE haemovigilance data.

Saadah NH, van der Bom JG, Wiersum-Osselton JC, Richardson C, Middelburg RA, Politis C, Renaudier P, Robillard P, Schipperus MR.

Br J Haematol. 2018 Mar;180(5):727-734. doi: 10.1111/bjh.15082. Epub 2018 Jan 9.

PMID:
29318576
8.

Direct costs of transfusion reactions - an expert judgement approach.

Janssen MP, van Tilborgh AJW, de Vooght KMK, Bokhorst AG, Wiersum-Osselton JC.

Vox Sang. 2018 Feb;113(2):143-151. doi: 10.1111/vox.12614. Epub 2017 Nov 9.

PMID:
29124766
9.

Comparing transfusion reaction rates for various plasma types: a systematic review and meta-analysis/regression.

Saadah NH, van Hout FMA, Schipperus MR, le Cessie S, Middelburg RA, Wiersum-Osselton JC, van der Bom JG.

Transfusion. 2017 Sep;57(9):2104-2114. doi: 10.1111/trf.14245. Epub 2017 Aug 2. Review.

PMID:
28766723
10.

Storage medium of platelet transfusions and the risk of transfusion-transmitted bacterial infections.

Kreuger AL, Middelburg RA, Kerkhoffs JH, Schipperus MR, Wiersum-Osselton JC, van der Bom JG.

Transfusion. 2017 Mar;57(3):657-660. doi: 10.1111/trf.13969. Epub 2017 Jan 31.

PMID:
28144957
11.

Donors' health state the year after peripheral haematopoietic progenitor cell collection: A prospective follow-up study in related and unrelated donors compared to first-time platelet donors.

Bank I, Wiersum-Osselton JC, Van Walraven SM, Netelenbos T, Fechter M, Marijt-van der Kreek T, Bär BM, Van der Bom JG, Brand A.

J Clin Apher. 2016 Dec;31(6):523-528. doi: 10.1002/jca.21444. Epub 2016 Jan 27.

PMID:
26812941
12.

Quality indicators for the hospital transfusion chain: a national survey conducted in 100 dutch hospitals.

Zijlker-Jansen PY, Janssen MP, van Tilborgh-de Jong AJ, Schipperus MR, Wiersum-Osselton JC.

Vox Sang. 2015 Oct;109(3):287-95. doi: 10.1111/vox.12281. Epub 2015 Apr 20.

PMID:
25898854
13.

Presence of medication taken by blood donors in plasma for transfusion.

van Tilborgh-de Jong AJ, Wiersum-Osselton JC, Touw DJ, Schipperus MR.

Vox Sang. 2015 May;108(4):323-7. doi: 10.1111/vox.12230. Epub 2014 Dec 30.

PMID:
25557151
14.

Wrong blood in tube - potential for serious outcomes: can it be prevented?

Bolton-Maggs PH, Wood EM, Wiersum-Osselton JC.

Br J Haematol. 2015 Jan;168(1):3-13. doi: 10.1111/bjh.13137. Epub 2014 Oct 4. Review.

PMID:
25284036
15.

Observational etiologic research. Part 4--Matching in case-control studies: almost always a bad idea.

Middelburg RA, Wiersum-Osselton JC, van de Watering LM, van der Bom JG.

Transfusion. 2014 Feb;54(2):267-70. doi: 10.1111/trf.12419. Epub 2013 Sep 30. No abstract available.

PMID:
24117702
16.

Observational etiologic research: part 1--The etiologic research question: it requires DATA.

Middelburg RA, Wiersum-Osselton JC, van de Watering LM, van der Bom JG.

Transfusion. 2013 Nov;53(11):2606-8. doi: 10.1111/trf.12417. Epub 2013 Sep 30. No abstract available.

PMID:
24117626
17.

Observational etiologic research: part 2--effect measures in etiologic research.

Middelburg RA, Wiersum-Osselton JC, van de Watering LM, van der Bom JG.

Transfusion. 2013 Dec;53(12):3048-51. doi: 10.1111/trf.12416. Epub 2013 Sep 30. No abstract available.

PMID:
24117605
18.

Observational etiologic research: part 3-case-control studies: it's all about the source population.

Middelburg RA, Wiersum-Osselton JC, van de Watering LM, van der Bom JG.

Transfusion. 2014 Jan;54(1):12-6. doi: 10.1111/trf.12415. Epub 2013 Sep 30. No abstract available.

PMID:
24117524
19.

Risk factors for complications in donors at first and repeat whole blood donation: a cohort study with assessment of the impact on donor return.

Wiersum-Osselton JC, Marijt-van der Kreek T, Brand A, Veldhuizen I, van der Bom JG, de Kort W.

Blood Transfus. 2014 Jan;12 Suppl 1:s28-36. doi: 10.2450/2013.0262-12. Epub 2013 Jun 3.

20.

Plasmapheresis in healthy donors in the Netherlands: cohort study of risk factors for donor complications.

Wiersum-Osselton JC, Marijt-van der Kreek T, van Dongen R.

Transfus Apher Sci. 2013 Apr;48(2):163. doi: 10.1016/j.transci.2013.02.018. Epub 2013 Mar 14. No abstract available.

PMID:
23809816
21.

Quality validation of data in national haemovigilance systems in Europe: report of a survey on current state of practice.

Wiersum-Osselton JC, Faber JC, Politis C, Brand A, van der Bom JG, Schipperus MR.

Vox Sang. 2013 Apr;104(3):214-7. doi: 10.1111/j.1423-0410.2012.01659.x. Epub 2012 Oct 13.

PMID:
23061879
22.

Variation between hospitals in rates of reported transfusion reactions: is a high reporting rate an indicator of safer transfusion?

Wiersum-Osselton JC, van Tilborgh-de Jong AJ, Zijlker-Jansen PY, van de Watering LM, Brand A, van der Bom JG, Schipperus MR.

Vox Sang. 2013 Feb;104(2):127-34. doi: 10.1111/j.1423-0410.2012.01642.x. Epub 2012 Aug 15.

PMID:
22892067
23.

Clinical outcomes after peripheral blood stem cell donation by related donors: a Dutch single-center cohort study.

Wiersum-Osselton JC, van Walraven SM, Bank I, Lenselink AM, Fibbe WE, van der Bom JG, Brand A.

Transfusion. 2013 Jan;53(1):96-103. doi: 10.1111/j.1537-2995.2012.03676.x. Epub 2012 May 3.

PMID:
22554279
24.

Measures to prevent transfusion-related acute lung injury (TRALI).

Reesink HW, Lee J, Keller A, Dennington P, Pink J, Holdsworth R, Schennach H, Goldman M, Petraszko T, Sun J, Meng Y, Qian K, Rehacek V, Turek P, Krusius T, Juvonen E, Tiberghien P, Legrand D, Semana G, Muller JY, Bux J, Reil A, Lin CK, Daly H, McSweeney E, Porretti L, Greppi N, Rebulla P, Okazaki H, Sánchez-Guerrero SA, Baptista-González HA, Martínez-Murillo C, Guerra-Márquez A, Rodriguez-Moyado H, Middelburg RA, Wiersum-Osselton JC, Brand A, van Tilburg C, Dinesh D, Dagger J, Dunn P, Brojer E, Letowska M, Maslanka K, Lachert E, Uhrynowska M, Zhiburt E, Palfi M, Berlin G, Frey BM, Puig Rovira L, Muñiz-Diaz E, Castro E, Chapman C, Green A, Massey E, Win N, Williamson L, Silliman CC, Chaffin DJ, Ambruso DR, Blumberg N, Tomasulo P, Land KJ, Norris PJ, Illoh OC, Davey RJ, Benjamin RJ, Eder AF, McLaughlin L, Kleinman S, Panzer S.

Vox Sang. 2012 Oct;103(3):231-59. doi: 10.1111/j.1423-0410.2012.01596.x. Epub 2012 Apr 20. No abstract available.

PMID:
22519920
25.

Allo-exposure status and leucocyte antibody positivity of blood donors show a similar relation with TRALI.

Middelburg RA, Beckers EA, Porcelijn L, Lardy N, Wiersum-Osselton JC, Schipperus MR, Vrielink H, Briët E, van der Bom JG.

Transfus Med. 2012 Apr;22(2):128-32. doi: 10.1111/j.1365-3148.2012.01140.x. Epub 2012 Mar 1.

PMID:
22380759
26.

Donor vigilance: what are we doing about it?

Wiersum-Osselton JC, Marijt-van der Kreek T, de Kort WL.

Biologicals. 2012 May;40(3):176-9. doi: 10.1016/j.biologicals.2011.12.003. Epub 2012 Jan 9.

PMID:
22230318
27.

Alloexposed blood donors and transfusion-related acute lung injury: a case-referent study.

Middelburg RA, van Stein D, Atsma F, Wiersum-Osselton JC, Porcelijn L, Beckers EA, Briët E, van der Bom JG.

Transfusion. 2011 Oct;51(10):2111-7. doi: 10.1111/j.1537-2995.2011.03118.x. Epub 2011 Mar 24.

PMID:
21985044
28.

Storage time of blood products and transfusion-related acute lung injury.

Middelburg RA, Borkent-Raven BA, Janssen MP, van de Watering LM, Wiersum-Osselton JC, Schipperus MR, Beckers EA, Briët E, van der Bom JG.

Transfusion. 2012 Mar;52(3):658-67. doi: 10.1111/j.1537-2995.2011.03352.x. Epub 2011 Sep 26. Erratum in: Transfusion. 2012 Jun;52(6):1386. Borkent, Barbara [corrected to Borkent-Raven, Barbara A]; Jansen, Mart [corrected to Janssen, Mart P].

PMID:
21950582
29.

Male-only fresh-frozen plasma for transfusion-related acute lung injury prevention: before-and-after comparative cohort study.

Wiersum-Osselton JC, Middelburg RA, Beckers EA, van Tilborgh AJ, Zijlker-Jansen PY, Brand A, van der Bom JG, Schipperus MR.

Transfusion. 2011 Jun;51(6):1278-83. doi: 10.1111/j.1537-2995.2010.02969.x. Epub 2010 Dec 6.

PMID:
21133929
30.

[International databases: usefulness and limitations in hemovigilance].

Wiersum-Osselton JC.

Transfus Clin Biol. 2010 Dec;17(5-6):306-9. doi: 10.1016/j.tracli.2010.09.158. Epub 2010 Nov 4. Review. French.

PMID:
21055991
31.

Haemovigilance for the optimal use of blood products in the hospital.

Reesink HW, Panzer S, Gonzalez CA, Lena N, Muntaabski P, Gimbatti S, Wood E, Lambermont M, Deneys V, Sondag D, Alport T, Towns D, Devine D, Turek P, Auvinen MK, Koski T, Lin CK, Lee CK, Tsoi WC, Lawlor E, Grazzini G, Piccinini V, Catalano L, Pupella S, Kato H, Takamoto S, Okazaki H, Hamaguchi I, Wiersum-Osselton JC, Van Tilborgh AJ, Zijlker-Jansen PY, Mangundap KM, Schipperus MR, Dinesh D, Flanagan P, Flesland Ø, Steinsvåg CT, Espinosa A, Letowska M, Rosiek A, Antoniewicz-Papis J, Lachert E, Koh MB, Alcantara R, Corral Alonso M, Muñiz-Diaz E.

Vox Sang. 2010 Oct;99(3):278-93. doi: 10.1111/j.1423-0410.2010.01323.x. No abstract available.

PMID:
20345518
32.

[Transfusion-related acute lung injury (TRALI) in the Netherlands in 2002-2005].

Wiersum-Osselton JC, Porcelijn L, van Stein D, Vlaar AP, Beckers EA, Schipperus MR.

Ned Tijdschr Geneeskd. 2008 Aug 9;152(32):1784-8. Dutch.

PMID:
18754313
33.

Response to the international forum on haemovigilance.

Wiersum-Osselton JC, Schipperus MR.

Vox Sang. 2006 Oct;91(3):278-9. No abstract available.

PMID:
16958843
34.

[Transfusion reactions in patients: haemovigilance reports to the Dutch National Haemovigilance Office in 2003].

Wiersum-Osselton JC, Schipperus MR.

Ned Tijdschr Geneeskd. 2005 Nov 19;149(47):2622-7. Dutch.

PMID:
16355575

Supplemental Content

Loading ...
Support Center